The W.A. de Vigier Award is the oldest and highest endowed prize for startups in Switzerland, giving away five awards of CHF 100’000 each. Applications are open until January 6th. Since 1989, the foundation has distributed over CHF 11 million of seed money, resulting in more than 90 thriving Swiss startups, successful IPOs, multiple company […]
Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Hemex Team Press Release
HEMEX opens subsidiary in Belgium, expanding its presence in the EU
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
At HEMEX, we regularly organize invitation-only pitch days, where selected startups get the opportunity to pitch in front of potential investors. The focus of our last 2019 pitch session was on startups seeking to revolutionize cancer diagnosis and treatment. Thank you Christina Vallgren, Marcus Palm, Martin Stauber, Seline Eisenring, Michael Krauthammer and Peter Nestorov for […]